| Model 4 - treated | Model 5 - treated (with mastectomy) | ||||||
---|---|---|---|---|---|---|---|---|
Subhazard Risk Ratio | 95% CIs | z | p > |z| | Subhazard Risk Ratio | 95% CIs | z | p > |z| | |
Aboriginal | ||||||||
 No |  |  |  |  |  |  |  |  |
 Yes |  |  |  |  |  |  |  |  |
Stage at diagnosis | ||||||||
 Local | 1.00 | Reference |  |  | 1.00 | Reference |  |  |
  Regional | 34.23 | 6.76–173.40 | 4.27 | 0.000 | 48.81 | 3.63–655.42 | 2.93 | 0.003 |
 Distant or Unknown | 49.67 | 6.79–363.51 | 3.85 | 0.000 | 69.21 | 4.21–1138.25 | 2.97 | 0.003 |
Listed with BSSA | ||||||||
 No |  |  |  |  |  |  |  |  |
 Yes |  |  |  |  |  |  |  |  |
Screened by BSSA | ||||||||
 No | 1.00 | Reference |  |  | 1.00 | Reference |  |  |
 Yes | 0.07 | 0.01–0.83 | −2.11 | 0.035 | 0.05 | 0.01–0.40 | −2.78 | 0.005 |
Systemic therapy | ||||||||
 No | 1.00 | Reference |  |  | 1.00 | Reference |  |  |
 Yes | 0.06 | 0.01–0.41 | −2.88 | 0.004 | 0.05 | 0.01–0.21 | −4.11 | 0.000 |
Surgical treatment | ||||||||
 No | 1.00 | Reference |  |  |  |  |  |  |
 Yes | 0.17 | 0.04–0.74 | −2.36 | 0.018 |  |  |  |  |
Mastectomy | ||||||||
 No mastectomy |  |  |  |  | 1.00 | Reference |  |  |
 Partial |  |  |  |  | 0.10 | 0.01–0.88 | −2.08 | 0.038 |
 Simple/ subcutaneous |  |  |  |  | 0.23 | 0.06–0.86 | −2.19 | 0.029 |
 AIC | 28.9 |  |  |  | 28.9 |  |  |  |